Biotech · Private company
OncoResponse, Inc.
Track this companyFree. Adds OncoResponse, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- CemiplimabPhase 2 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- DocetaxelPhase 2 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- OR2805Phase 2 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- OR502Phase 2 · CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer AgentsPHASE1_PHASE2 · RECRUITING · started Oct 24, 2023ClinicalTrials.gov NCT06090266 · fetched Nov 12, 2026
- A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer AgentsPHASE1_PHASE2 · UNKNOWN · started Sep 9, 2021ClinicalTrials.gov NCT05094804 · fetched Nov 12, 2026